A conversation with McGill’s ‘guru’ of mRNA
Canada’s leading expert on mRNA, Nahum Sonenberg, PhD, is the Gilman Cheney Chair in Biochemistry at McGill University’s Rosalind and Morris Goodman Cancer Institute. Prof…
Maureen McKeague on how McGill’s interdisciplinary team could uncover the multifaceted potential of artificial RNA
Interdisciplinarity has always been central to the research of Maureen McKeague, PhD. As a joint Assistant Professor between the Department of Pharmacology and Therapeutics at the…
From the study of what dictates protein output from mRNAs, to blocking mRNA expression, McGill’s Jerry Pelletier has storied history of RNA research
Jerry Pelletier, PhD, a Professor at McGill University’s Department of Biochemistry and Department of Oncology, and a member of the Rosalind and Morris Goodman Cancer Institute, is…
How RNA research could provide valuable insights into rare inherited tumours
William Foulkes, MBBS, PhD, is a James McGill Professor in the Departments of Medicine, Oncology and Human Genetics at McGill University and a researcher-clinician who has…
Translating intelligent biomaterials into precision medicine
Guojun Chen, PhD, arrived at McGill to take up his new post in January 2021 — in the middle of the pandemic. He quarantined in a hotel for two weeks, then set up his lab, and began…
Dr. Nahum Sonenberg and his scientific contribution to mRNA biology
mRNA vaccines are a breakthrough in science innovation demonstrating the speed and flexibility to respond to a global pandemic. A huge support for this scientific advance was the…